No Data
No Data
Christopher Hui: The Hong Kong Stock Exchange has taken into account the needs of different investors when implementing the optimized mechanism for IPO pricing and allocation.
Xu Zhengyu mentioned that the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange will continue to closely review the quality of sponsor work and listing applications, and take appropriate regulatory actions when necessary to uphold Hong Kong's reputation as a leading international fundraising hub.
IPO Outlook | Boasting the largest production capacity in Asia, but struggling to mask profit concerns: What are the chances of Weikang Probiotics succeeding in its HKEX listing?
The confidence behind Weikang Probiotics' decision to go public in Hong Kong at this time stems not only from the dividends of the trillion-dollar health market but also from its firm belief in the technological route that has enabled China's domestic probiotics industry to transition from "catching up" to "leading the way."
IPO News | Microecology Probiotics Submits Listing Application to HKEX Main Board, Specializing in the R&D, Production, and Sales of Probiotic Strains
According to a disclosure by the Hong Kong Stock Exchange on April 29, Weikang Probiotics (Suzhou) Co., Ltd. submitted an application for listing on the Main Board of the Hong Kong Stock Exchange, with Guotai Haitong serving as the sole sponsor.